AI is increasingly used to accelerate and improve drug discovery and development. AI tools, like AlphaFold and autonomous labs, help identify targets and process massive datasets. Regulatory standards ...
Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.
Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...
A new laser technique decodes molecular vibrations to predict whether a drug will be effective, potentially cutting years ...
Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...
Hosted on MSN
MindRank in phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its ...
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals—a discovery that could accelerate and improve how medicines ...
Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...
It’s the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster. Pharmaceutical giant Roche said today it is launching a new large-scale “AI factory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results